105 related articles for article (PubMed ID: 8030150)
1. Aminoterminal propeptide of type III procollagen reflects formation of collagen following rejection after heart transplantation.
Høst NB; Aldershvile J; Jensen LT; Mortensen SA; Pettersson G; Høyer S; Haunsø S
Transplant Proc; 1994 Jun; 26(3):1813. PubMed ID: 8030150
[No Abstract] [Full Text] [Related]
2. Serum aminoterminal propeptide of type III procollagen after cardiac transplantation and the effect of rejection.
Høst NB; Aldershvile J; Hørslev-Petersen K; Høyer S; Haunsø S
Am J Cardiol; 1996 Dec; 78(12):1406-10. PubMed ID: 8970415
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function.
Bader FM; Rogers RK; Kfoury AG; Gilbert EM; Horne BD; Stehlik J; Renlund DG
Congest Heart Fail; 2009; 15(2):63-7. PubMed ID: 19379451
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase and carbonyl proteins: promising markers for non-invasive monitoring of graft rejection after heart transplantation.
Koestenbauer S; Stiegler P; Stadlbauer V; Mayrhauser U; Leber B; Schweiger M; Wasler A; Prenner G; Sereinigg M; Zelzer S; Stojakovic T; Scarpatetti M; Griesbacher A; Greilberger J; Tscheliessnigg K
J Heart Lung Transplant; 2010 Dec; 29(12):1352-7. PubMed ID: 20591692
[TBL] [Abstract][Full Text] [Related]
5. Association of amino-terminal propeptide of type III procollagen and acute myocardial rejection in male patients receiving heart transplantation.
Lin YH; Liu CP; Hsu RB; Lee CM; Wang SS; Kao HL; Chao CL; Shiau YC; Hung CS; Liao LC; Ho YL
Clin Chem Lab Med; 2007; 45(8):1004-8. PubMed ID: 17867989
[TBL] [Abstract][Full Text] [Related]
6. Endothelin plasma levels in acute graft rejection after heart transplantation.
Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
[TBL] [Abstract][Full Text] [Related]
7. Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats.
Hørslev-Petersen K; Kim KY; Pedersen LR; Bentsen KD; Uldbjerg N; Oxlund H; Garbarsch C; Hahn EG; Schuppan D; Lorenzen I
APMIS; 1988 Sep; 96(9):793-804. PubMed ID: 3048338
[TBL] [Abstract][Full Text] [Related]
8. Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer.
Santala M; Simojoki M; Risteli J; Risteli L; Kauppila A
Clin Cancer Res; 1999 Dec; 5(12):4091-6. PubMed ID: 10632345
[TBL] [Abstract][Full Text] [Related]
9. Surrogate markers of rejection.
Austin BA; Taylor DO
Curr Opin Organ Transplant; 2010 Oct; 15(5):645-9. PubMed ID: 20651597
[TBL] [Abstract][Full Text] [Related]
10. C4d complement component as one of the humoral rejection markers.
Beletskaya LV; Baranova FS; Kupriyanova AG
J Heart Lung Transplant; 2005 Aug; 24(8):1125-6. PubMed ID: 16102454
[No Abstract] [Full Text] [Related]
11. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
12. Intramyocardial electrograms for the monitoring of allograft rejection after heart transplantation using spontaneous and paced beats.
Auer T; Schreier G; Hutten H; Tscheliessnigg KH; Allmayr T; Grasser B; Iberer F; Wasler A; Petutschnigg B; Müller H
Transplant Proc; 1995 Oct; 27(5):2621-4. PubMed ID: 7482856
[No Abstract] [Full Text] [Related]
13. Neopterin changes after clinical heart transplantation.
Wang SS; Chu SH; Ko WJ
Transplant Proc; 1996 Jun; 28(3):1730-2. PubMed ID: 8658860
[No Abstract] [Full Text] [Related]
14. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients.
Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273
[TBL] [Abstract][Full Text] [Related]
15. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
[TBL] [Abstract][Full Text] [Related]
16. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A
Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-brain natriuretic peptide as a potential non-invasive marker of cardiac transplantation rejection.
Avello N; Molina BD; Llorente E; Bernardo MJ; Prieto B; Alvarez FV
Ann Clin Biochem; 2007 Mar; 44(Pt 2):182-8. PubMed ID: 17362585
[TBL] [Abstract][Full Text] [Related]
18. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
19. Value of NT-proBNP determinations in the follow-up of heart transplantation.
Cuppoletti A; Roig E; Pérez-Villa F; Marin JL; Orús J; Vallejos I; Rivera A; Botta C
Transplant Proc; 2005 Nov; 37(9):4033-5. PubMed ID: 16386619
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide levels late after transplant predict graft survival in pediatric heart transplant patients.
Rossano JW; Denfield SW; Kim JJ; Price JF; Jefferies JL; Decker JA; Dreyer WJ
J Heart Lung Transplant; 2010 Mar; 29(3):385-6. PubMed ID: 19782608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
